S. El-Chemaly

发表

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

J. Eu, M. Fishbein, D. Kreisel, 2017, JCI insight.

Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis

Raúl San José Estépar, G. Washko, J. Ross, 2017, Respiratory Research.

Hospital admissions after paediatric trauma in a developing country: from falls to landmines

S. El-Chemaly, H. Tamim, M. Atoui, 2007, International journal of injury control and safety promotion.

Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

J. Moss, M. Moses, Connie G. Glasgow, 2010, Respiratory medicine.

Intratracheal transplantation of trophoblast stem cells attenuates acute lung injury in mice

I. Rosas, J. Lederer, S. Kourembanas, 2021, Stem cell research & therapy.

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

E. Henske, J. Moss, M. Stylianou, 2017, Cancer research.

Lactoperoxidase and human airway host defense.

G. Conner, M. Salathe, S. El-Chemaly, 2003, American journal of respiratory cell and molecular biology.

Lymphatic Vessels: The Next Frontier in Lung Transplant

G. Visner, S. El-Chemaly, Kaifeng Liu, 2017, Annals of the American Thoracic Society.

Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease.

P. Camp, I. Rosas, B. Raby, 2015, Chest.

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.

J. Moss, Jing-Ping Lin, S. El-Chemaly, 2010, American journal of respiratory and critical care medicine.

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial

D. Bienfang, E. Henske, J. Moss, 2017, Chest.

An Ethical Framework for the Care of Patients with Prolonged Hospitalization Following Lung Transplantation

S. El-Chemaly, J. Diamond, H. Goldberg, 2018, HEC Forum.

Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2011, American journal of physiology. Lung cellular and molecular physiology.

A Phase II Clinical Trial of Low‐Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis

H. Collard, F. Martinez, I. Noth, 2018, Chest.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes

Raúl San José Estépar, G. Washko, E. Silverman, 2017, European Respiratory Journal.

Transforming Growth Factor-β 1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via the Jun NH 2-Terminal Kinase Signaling Pathway

Hao Wang, Ying Shi, I. Rosas, 2015 .

Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.

Jianhua Yao, W. Gahl, D. Malide, 2013, Chest.

Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis

A. Choi, I. Rosas, J. Elias, 2015, PloS one.

Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?

S. El-Chemaly, Ye Cui, Anthony M. Lamattina, 2017, American journal of respiratory cell and molecular biology.

[18F]Fluorocholine and [18F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM

M. Kijewski, G. El Fakhri, W. Oldham, 2018, Clinical Cancer Research.

Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblasts.

D. Malide, J. Moss, J. Kato, 2014, American journal of respiratory cell and molecular biology.

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms

D. Malide, J. Moss, S. Nathan, 2009, Proceedings of the National Academy of Sciences.

Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.

D. Malide, J. Moss, S. El-Chemaly, 2009, Lymphatic research and biology.

Characterization of lymphangioleiomyomatosis patients with discordance between spirometric and diffusion measurements of pulmonary function

C. Carvalho, E. Henske, I. Rosas, 2018, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Radiation-induced impairment in lung lymphatic vasculature.

Hao Wang, J. McDonald, A. Gigliotti, 2014, Lymphatic research and biology.

Smoking patterns and predictors of smoking cessation in elderly populations in Lebanon.

A. Mehio-Sibai, S. El-Chemaly, M. Chaaya, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Single Cell RNA-seq and Mass Cytometry Reveals a Novel and a Targetable Population of Macrophages in Idiopathic Pulmonary Fibrosis

G. Washko, C. Coarfa, N. Kaminski, 2021, bioRxiv.

Telomeres in Interstitial Lung Disease: The Short and the Long of It

S. El-Chemaly, A. Courtwright, 2019, Annals of the American Thoracic Society.

Emerging biomarkers of lymphangioleiomyomatosis

E. Henske, S. El-Chemaly, Julie Nijmeh, 2018, Expert review of respiratory medicine.

Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts

S. Ryter, Bo Sun, K. Tsoyi, 2022, Scientific Reports.

Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia.

B. Levy, C. Serhan, N. Petasis, 2016, The American journal of pathology.

Clinical Outcomes of Lung Transplantation in the Presence of Donor-specific Antibodies.

H. Mallidi, S. El-Chemaly, H. Goldberg, 2019, Annals of the American Thoracic Society.

Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta‐analysis

E. Milford, I. Guleria, S. El-Chemaly, 2018, HLA.

Pathophysiology of Lymphangioleiomyomatosis

E. Henske, J. Moss, S. El-Chemaly, 2021 .

The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials

E. Henske, S. El-Chemaly, 2015, Expert review of respiratory medicine.

Involvement of lymphatics in lymphangioleiomyomatosis.

J. Moss, S. El-Chemaly, Xiong Cai, 2009, Lymphatic research and biology.

Mesenchymal stromal cells expressing a dominant‐negative high mobility group A1 transgene exhibit improved function during sepsis

J. Lederer, A. Castano, S. El-Chemaly, 2021, Journal of leukocyte biology.

Lymphatics in Lung Disease

J. Moss, S. Levine, S. El-Chemaly, 2008, Annals of the New York Academy of Sciences.

Hydrogen peroxide-scavenging properties of normal human airway secretions.

G. Conner, M. Salathe, S. El-Chemaly, 2003, American journal of respiratory and critical care medicine.

The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death

P. Camp, I. Rosas, E. Milford, 2017, Transplantation.

Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates.

P. Camp, E. Milford, I. Guleria, 2014, American journal of respiratory and critical care medicine.

The lung microbiome in end-stage Lymphangioleiomyomatosis

J. Moss, I. Rosas, Yvonne J. Huang, 2021, Respiratory Research.

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

Hao Wang, I. Rosas, G. Visner, 2015, The Journal of clinical investigation.

Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival

Suneet Agarwal, I. Rosas, B. Raby, 2020, ERJ Open Research.

Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine.

E. Henske, J. Moss, Yan Tang, 2019, Chest.

Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine.

E. Henske, J. Moss, Yan Tang, 2019, Chest.

Statins in lymphangioleiomyomatosis: a word of caution

J. Moss, M. Stylianou, S. El-Chemaly, 2009, European Respiratory Journal.

Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals

H. Hatabu, L. Digianni, I. Rosas, 2021, Thorax.

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis

E. Thiele, E. Henske, I. Rosas, 2019, Orphanet Journal of Rare Diseases.

Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility

D. Maynard, M. Malicdan, I. Rosas, 2022, Respiratory Research.

Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients

I. Rosas, M. Divo, S. El-Chemaly, 2019, Scientific Reports.

Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation.

W. Gahl, N. Young, J. Moss, 2011, Chest.

Mutation Subjects With the Same Telomerase Natural History of Pulmonary Fibrosis in Two

W. Gahl, N. Young, J. Moss, 2011 .

Familial Pulmonary Fibrosis: Natural History Of Preclinical Disease

W. Gahl, J. Moss, S. El-Chemaly, 2010, ATS 2010.

Blocking hyaluronan synthesis alleviates acute lung allograft rejection

J. Azzi, I. Rosas, G. Visner, 2021, JCI insight.

Hermansky-Pudlak Syndrome.

L. Young, S. El-Chemaly, Lisa R Young, 2016, Clinics in chest medicine.

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis

E. Henske, S. El-Chemaly, H. Goldberg, 2017, European Respiratory Review.

Editorial: Advances and Updates in Diffuse Cystic Lung Diseases

Kaifeng Xu, S. El-Chemaly, B. Baldi, 2021, Frontiers in Medicine.

Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?

S. El-Chemaly, H. Goldberg, A. Glanville, 2014, Expert review of respiratory medicine.

Exposure of pre-school children to passive cigarette and narghile smoke in Beirut.

A. El-Zein, S. El-Chemaly, H. Tamim, 2006, European journal of public health.

Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation.

S. Ryter, A. Choi, I. Rosas, 2016, American journal of respiratory cell and molecular biology.

Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis.

S. El-Chemaly, A. Courtwright, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation

Suneet Agarwal, I. Rosas, E. Milford, 2016, PloS one.

Airway complications in lung transplant recipients with telomere‐related interstitial lung disease

R. Borie, M. Reynaud‐Gaubert, S. El-Chemaly, 2021, Clinical transplantation.

Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1

J. Moss, J. Kato, M. Stylianou, 2011, Proceedings of the National Academy of Sciences.

Palmitic Acid-Rich High Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress.

K. Tsoyi, F. Hsu, I. Rosas, 2019, American journal of respiratory cell and molecular biology.

Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study

S. El-Chemaly, L. Fredenburgh, R. Baron, 2020, American journal of respiratory and critical care medicine.

Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways

I. Rosas, C. Priolo, F. Wagner, 2019, PloS one.

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake

I. Rosas, G. Visner, S. El-Chemaly, 2020, Molecular medicine.

Cesarean delivery among nulliparous women in Beirut: assessing predictors in nine hospitals.

O. Campbell, A. Kaddour, K. Yunis, 2007, Birth.

Intratracheal transplantation of trophoblast stem cells attenuates acute lung injury in mice

I. Rosas, J. Lederer, S. Kourembanas, 2020, Stem Cell Research & Therapy.

Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death

E. Henske, C. Priolo, S. El-Chemaly, 2022, The Journal of biological chemistry.

Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.

P. Camp, I. Rosas, H. Mallidi, 2017, The Annals of thoracic surgery.

Sesame oil use in ameliorating cough in children: a randomised controlled trial.

R. Sabra, N. Pashayan, S. El-Chemaly, 2006, Complementary therapies in medicine.

Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction.

P. Camp, A. Fuhlbrigge, I. Rosas, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.

J. Siegfried, S. Belinsky, K. Tsoyi, 2019, American journal of respiratory cell and molecular biology.

Mesenchymal stromal cell‐derived syndecan‐2 regulates the immune response during sepsis to foster bacterial clearance and resolution of inflammation

K. Tsoyi, I. Rosas, S. Kourembanas, 2021, The FEBS journal.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

G. Washko, M. Weinblatt, N. Shadick, 2015, American journal of respiratory and critical care medicine.

Biobanking and cryopreservation of human lung explants for omic analysis

G. Washko, Kazuhisa Konishi, A. Choi, 2019, European Respiratory Journal.

Trauma epidemiology and outcome in a developing country: perspectives from a university teaching hospital in Beirut

F. Jamali, M. Jaana, H. Tamim, 2006, International journal of injury control and safety promotion.

The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study.

I. Guleria, S. El-Chemaly, P. Burkett, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Genetics and Idiopathic Interstitial Pneumonias

I. Rosas, S. El-Chemaly, S. Chu, 2016, Seminars in Respiratory and Critical Care Medicine.

Syndecan‐2 Attenuates Radiation‐induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148

J. McDonald, K. Tsoyi, I. Rosas, 2017, American journal of respiratory cell and molecular biology.

The Immunome in Two Inherited Forms of Pulmonary Fibrosis

Yuri Kotliarov, Angélique Biancotto, William A. Gahl, 2018, Front. Immunol..

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres

S. El-Chemaly, J. Kennedy, H. Goldberg, 2020, Frontiers in Immunology.

Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes

H. Collard, F. Martinez, I. Noth, 2019, Scientific Reports.

Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer

E. Henske, S. El-Chemaly, 2014, European Respiratory Review.

Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis

E. Henske, J. Moss, I. Rosas, 2018, Chest.

Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.

H. Hatabu, L. Digianni, I. Rosas, 2020, American journal of respiratory and critical care medicine.

Donor-acquired fat embolism syndrome after lung transplantation.

P. Camp, A. Fuhlbrigge, I. Rosas, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis

J. Moss, S. El-Chemaly, C. Glasgow, 2012, European Respiratory Review.

Pulmonary Vasculopathy Associated with FIGF Gene Mutation.

J. Stoler, S. El-Chemaly, S. Vargas, 2017, The American journal of pathology.

Prevalence and outcome of lung cancer in lung transplant recipients.

P. Camp, A. Fuhlbrigge, I. Rosas, 2015, Respiratory medicine.

Date of birth Height Weight Lung diagnosis Functional status Performs activities of daily living Some assistance Total assistance No assistance Diabetes Dependency unknown Not diabetic Insulin dependent Not insulin dependent Mechanical ventilation

S. El-Chemaly, Katherine A. Dudley, 2012 .

Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens

S. Nathan, M. Malicdan, S. El-Chemaly, 2021, Frontiers in Medicine.

Cardiopulmonary Exercise Testing in Lung Transplantation: A Review

S. El-Chemaly, Katherine A. Dudley, 2012, Pulmonary medicine.

Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells

J. Asara, E. Henske, S. El-Chemaly, 2021, Proceedings of the National Academy of Sciences.

Transforming Growth Factor-β1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via the Jun NH2-Terminal Kinase Signaling Pathway

Ying Shi, I. Rosas, Hao Wang, 2014, Molecular medicine.

An Ethical Framework for the Care of Patients with Prolonged Hospitalization Following Lung Transplantation

S. El-Chemaly, J. Diamond, H. Goldberg, 2018, HEC Forum.

What are the risks of pulmonary complications after cardiac surgery? Prolonged ventilation can be a major obstacle

A. Abreu, B. Krieger, S. El-Chemaly, 2003 .

Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.

S. El-Chemaly, P. Dellaripa, H. Goldberg, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Quantitative computed tomography assessment of bronchiolitis obliterans syndrome after lung transplantation

Raúl San José Estépar, George R Washko, Raul San Jose Estepar, 2017, Clinical transplantation.

Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation

W. Gahl, S. Nathan, I. Rosas, 2018, PloS one.

Spontaneous Pneumothoraces in Patients with Birt‐Hogg‐Dubé Syndrome

E. Henske, N. Gupta, E. Kopras, 2017, Annals of the American Thoracic Society.

Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis

A. Thorner, D. Kwiatkowski, E. Henske, 2019, European Respiratory Journal.

ETV2 regulates PARP-1 binding protein to induce ER stress–mediated death in tuberin-deficient cells

Abhijeet R. Sonawane, W. Qiu, E. Henske, 2022, Life Science Alliance.

ETV2 regulates PARP-1 binding protein to induce ER stress-mediated cell death in tuberin-deficient cells

Abhijeet R. Sonawane, E. Henske, J. Moss, 2021 .

Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Raúl San José Estépar, J. Hokanson, G. Washko, 2016, JAMA.

Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial

D. Kwiatkowski, E. Henske, J. Moss, 2020, European Respiratory Journal.

CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.

S. Ryter, K. Tsoyi, L. Celada, 2021, American journal of respiratory and critical care medicine.

Airway Complications in Lung Transplant Recipients with Telomere-Related Interstitial Lung Disease

R. Borie, M. Reynaud‐Gaubert, S. El-Chemaly, 2021 .

The injury severity score or the new injury severity score for predicting mortality, intensive care unit admission and length of hospital stay: experience from a university hospital in a developing country.

Adina Zeki Al Hazzouri, S. El-Chemaly, H. Tamim, 2008, Injury.

Expression of Stromal Cell–Derived Factor-1 by Mesenchymal Stromal Cells Impacts Neutrophil Function During Sepsis

R. Bronson, K. Tsoyi, J. Lederer, 2020, Critical care medicine.

Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients

I. Rosas, M. Divo, S. El-Chemaly, 2019, Scientific Reports.

In‐hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization

A. Thomasson, S. El-Chemaly, J. Diamond, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interstitial lung abnormalities are associated with decreased mean telomere length

G. Washko, E. Silverman, V. Gudnason, 2022, European Respiratory Journal.

Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation

David J. Wolfe, P. Camp, A. Fuhlbrigge, 2016, Clinical transplantation.

Suspected Interstitial Lung Disease in COPDGene.

G. Washko, E. Silverman, M. Cho, 2022, American journal of respiratory and critical care medicine.

1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease

H. Mallidi, S. El-Chemaly, J. Kennedy, 2021, ERJ Open Research.

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion

E. Henske, I. Rosas, S. El-Chemaly, 2023, Jornal Brasileiro de Pneumologia.

Hydrogen peroxide-scavenging properties of normal human airway secretions.

G. Conner, M. Salathe, S. El-Chemaly, 2003, American journal of respiratory and critical care medicine.